Journal: Materials Today Bio
Article Title: Ultrasound-responsive hydrogel with ROS scavenging and NO controllable release capabilities for accelerated healing of diabetic wounds
doi: 10.1016/j.mtbio.2026.102796
Figure Lengend Snippet: Immunofluorescence and ELISA analysis of diabetic wound areas. Immunofluorescence staining images of CD31 in diabetic wound skin tissue on day 21 (A) and CD31 + neovascularization density (B). Immunofluorescence staining images of VEGF in diabetic wound skin tissue on day 21 (C) and the relative protein expression of VEGF (D). Immunofluorescence staining images of ROS in diabetic wound skin tissue on day 21 (E) and the relative protein expression of ROS (F). Immunofluorescence staining images of CD86 and CD206 in diabetic wound skin tissue on day 21 (G), and the corresponding ratio (H). ELISA analysis of TNF-α (I), IL-6 (J), and TGF-β (K) in diabetic wound skin tissue on day 21. (US parameters, 1 MHz, 0.7 W cm −2 ); n = 3, ∗P < 0.05, ∗∗P < 0.01 and ∗∗∗P < 0.001.
Article Snippet: ELISA kits for IL-6, TNF-α, and TGF-β, were supplied by BOSTER Biological Technology Co., Ltd. Primary antibodies against CD31 and VEGF, along with corresponding fluorescent secondary antibodies, were obtained from Abcam.
Techniques: Immunofluorescence, Enzyme-linked Immunosorbent Assay, Staining, Expressing